-
prescription medications like phentermine (a powerful stimulant that works by decreasing hunger and cravings) and bupropion (an antidepressant that affects the appetite center of the brain)
None of these compounds is mechanistically equivalent to retatrutide, but each contributes to the broader weight-loss-adjacent research landscape
23431, docket 2026-08552, published May 1, 2026) - removing semaglutide, tirzepatide, and liraglutide from the 503B outsourcing bulks list, with a public comment period through June 2026
These comparisons demonstrate the progression from single-receptor to multi-receptor approaches, with Retatrutide representing the most comprehensive triple agonist currently in development
Even if caloric intake remains similar, the metabolic effects can drive additional fat loss compared to GLP-1 only approaches